Clinical Trials Browser

Recurrence × navitoclax × Clear all

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT05740449 2024-06-21

HEM-iSMART A

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

HEM-iSMART A